Evidence map›Paper›PMID 40133518›Full record

ArticleNature biotechnology2026

High-dimensional imaging using combinatorial channel multiplexing and deep learning.

Raz Ben-Uri, Lior Ben Shabat, Dana Shainshein, Omer Bar-Tal, Yuval Bussi, Noa Maimon, Tal Keidar Haran, Idan Milo, Inna Goliand, Yoseph Addadi and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Raz Ben-Uri *Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-3300-058X
Lior Ben Shabat *Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Dana ShainsheinDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0009-0007-7979-8471
Omer Bar-TalDepartment of Mathematics and Computer Science, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0003-1622-3674
Yuval BussiDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0003-0365-431X
Noa MaimonDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0009-0001-1780-3104
Tal Keidar HaranDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0003-1931-706X
Idan MiloDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-2459-3061
Inna GoliandLife Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Yoseph AddadiLife Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0001-9827-0436
Tomer Meir SalameLife Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Alexander RochwargerDepartment of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.ORCID http://orcid.org/0009-0000-4272-7249
Christian M SchürchDepartment of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-1792-1768
Shai BagonDepartment of Mathematics and Computer Science, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-6057-4263
Ofer ElhananiDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Leeat KerenDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. leeat.keren@weizmann.ac.il.ORCID http://orcid.org/0000-0002-6799-6303

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 2481/20Israel Science Foundation (ISF) 94811
6 · The paper itself

Abstract

Understanding tissue structure and function requires tools that quantify the expression of multiple proteins at single-cell resolution while preserving spatial information. Current imaging technologies use a separate channel for each protein, limiting throughput and scalability. Here, we present combinatorial multiplexing (CombPlex), a combinatorial staining platform coupled with an algorithmic framework to exponentially increase the number of measured proteins. Every protein can be imaged in several channels and every channel contains agglomerated images of several proteins. These combinatorically compressed images are then decompressed to individual protein images using deep learning. We achieve accurate reconstruction when compressing the stains of 22 proteins to five imaging channels. We demonstrate the approach both in fluorescence microscopy and in mass-based imaging and show successful application across multiple tissues and cancer types. CombPlex can escalate the number of proteins measured by any imaging modality, without the need for specialized instrumentation.

Indexed as

Deep LearningImage Processing, Computer-AssistedProteinsAlgorithmsHumansMicroscopy, FluorescenceProteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.